Medical device company Boston Scientific (NYSE: BSX) will be announcing earnings results this Wednesday morning. Here’s what to expect.

Boston Scientific beat analysts’ revenue expectations by 3.4% last quarter, reporting revenues of $5.06 billion, up 22.8% year on year. It was a very strong quarter for the company, with a solid beat of analysts’ organic revenue estimates and an impressive beat of analysts’ revenue estimates.

Is Boston Scientific a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Boston Scientific’s revenue to grow 18.1% year on year to $4.97 billion, slowing from the 19.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.71 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Boston Scientific has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 3.2% on average.

Looking at Boston Scientific’s peers in the healthcare equipment and supplies segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Neogen’s revenues decreased 3.6% year on year, beating analysts’ expectations by 2.6%, and Abbott Laboratories reported revenues up 6.9%, in line with consensus estimates. Neogen traded up 3.7% following the results while Abbott Laboratories was down 4.2%.

Read our full analysis of Neogen’s results here and Abbott Laboratories’s results here.

There has been positive sentiment among investors in the healthcare equipment and supplies segment, with share prices up 4.7% on average over the last month. Boston Scientific is up 4.1% during the same time and is heading into earnings with an average analyst price target of $124.89 (compared to the current share price of $100.98).

P.S. While everyone's chasing Nvidia, we found a hidden AI semiconductor winner trading at a fraction of the price. See our #1 pick before Wall Street catches on.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.